Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Rorive

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Clinical Kidney Journal|October 2, 2023
Critically ill patients with acute kidney injury: clinical determinants and post-mortem histologyPatrick James Gleeson, Ilaria Alice Crippa, Aurélie Sannier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 25, 2014
PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosisBenjamin Bondue, Félicie Sherer, Gaetan Van Simaeys, et al.
Nature|August 13, 2015
Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneityAlexandra Van Keymeulen, May Yin Lee, Marielle Ousset, et al.
Contrast Media & Molecular Imaging|May 2, 2015
Development of a peptide-functionalized imaging nanoprobe for the targeting of (FXYD2)γa as a highly specific biomarker of pancreatic beta cellsCarmen Burtea, Sophie Laurent, Deborah Crombez, et al.
Molecular and Clinical Oncology|November 18, 2021
Immunohistochemistry as an accurate tool for the assessment of <i>BRAF V600E</i> and <i>TP53</i> mutations in primary and metastatic melanomaStefan Rusu, Camille Verocq, Anne Laure Trepant, et al.
International Journal of Cancer|June 13, 2014
Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathyHeinz H Schmeiser, Jöelle L Nortier, Rajinder Singh, et al.
Nature|June 10, 2014
SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinomaSoufiane Boumahdi, Gregory Driessens, Gaelle Lapouge, et al.
European Urology|April 5, 2011
Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non-muscle-invasive bladder cancerAlexandre R Zlotta, Thierry Roumeguere, Cynthia Kuk, et al.
Urology Annals|October 7, 2011
Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-GuérinSultan S Alkhateeb, Mischel Neill, Sas Bar-Moshe, et al.
Nature Cell Biology|November 27, 2012
Adult interfollicular tumour-initiating cells are reprogrammed into an embryonic hair follicle progenitor-like fate during basal cell carcinoma initiationKhalil Kass Youssef, Gaëlle Lapouge, Karine Bouvrée, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Clinical Kidney Journal|October 2, 2023
Critically ill patients with acute kidney injury: clinical determinants and post-mortem histologyPatrick James Gleeson, Ilaria Alice Crippa, Aurélie Sannier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 25, 2014
PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosisBenjamin Bondue, Félicie Sherer, Gaetan Van Simaeys, et al.
Nature|August 13, 2015
Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneityAlexandra Van Keymeulen, May Yin Lee, Marielle Ousset, et al.
Contrast Media & Molecular Imaging|May 2, 2015
Development of a peptide-functionalized imaging nanoprobe for the targeting of (FXYD2)γa as a highly specific biomarker of pancreatic beta cellsCarmen Burtea, Sophie Laurent, Deborah Crombez, et al.
Molecular and Clinical Oncology|November 18, 2021
Immunohistochemistry as an accurate tool for the assessment of <i>BRAF V600E</i> and <i>TP53</i> mutations in primary and metastatic melanomaStefan Rusu, Camille Verocq, Anne Laure Trepant, et al.
International Journal of Cancer|June 13, 2014
Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathyHeinz H Schmeiser, Jöelle L Nortier, Rajinder Singh, et al.
Nature|June 10, 2014
SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinomaSoufiane Boumahdi, Gregory Driessens, Gaelle Lapouge, et al.
European Urology|April 5, 2011
Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non-muscle-invasive bladder cancerAlexandre R Zlotta, Thierry Roumeguere, Cynthia Kuk, et al.
Urology Annals|October 7, 2011
Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-GuérinSultan S Alkhateeb, Mischel Neill, Sas Bar-Moshe, et al.
Nature Cell Biology|November 27, 2012
Adult interfollicular tumour-initiating cells are reprogrammed into an embryonic hair follicle progenitor-like fate during basal cell carcinoma initiationKhalil Kass Youssef, Gaëlle Lapouge, Karine Bouvrée, et al.
Pageof 7